After a confirmed pancreatitis while on tirzepatide, what is the most appropriate action?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $9.99Unlock all

Prepare for the Foundation Year Pharmacy Exam. Study with flashcards and multiple-choice questions. Each question comes with hints and explanations. Ensure your readiness for the exam!

Multiple Choice

After a confirmed pancreatitis while on tirzepatide, what is the most appropriate action?

Explanation:
Pancreatitis is a serious adverse event seen with incretin-based therapies, including tirzepatide. If pancreatitis is confirmed in a patient taking tirzepatide, the drug should be permanently discontinued and not rechallenged. Reintroducing tirzepatide could trigger another pancreatitis episode, with the risk outweighing any potential benefit. After resolution, choose alternative diabetes or weight-management options that do not involve tirzepatide. This is why stopping without restarting is the most appropriate action.

Pancreatitis is a serious adverse event seen with incretin-based therapies, including tirzepatide. If pancreatitis is confirmed in a patient taking tirzepatide, the drug should be permanently discontinued and not rechallenged. Reintroducing tirzepatide could trigger another pancreatitis episode, with the risk outweighing any potential benefit. After resolution, choose alternative diabetes or weight-management options that do not involve tirzepatide. This is why stopping without restarting is the most appropriate action.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy